Tomeko — every condition, connected. Open full hub →
Home  /  Disease hubs  /  Oculocutaneous albinism type 1

Oculocutaneous albinism type 1

Specialists and centers, recruiting clinical trials, patient organizations, research, and community for Oculocutaneous albinism type 1 — brought together in one place.

Open the full interactive hub for Oculocutaneous albinism type 1 →

Find specialists Clinical trials Patient organizations Research & market

Just diagnosed with Oculocutaneous albinism type 1?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Oculocutaneous albinism type 1, look for clinical trials, and connect with others living with it — all in one place.

Open the full interactive Oculocutaneous albinism type 1 hub →

Overview

Oculocutaneous albinism type 1 is a rare condition. Also known as OCA1. Tomeko brings together the specialists, research, clinical trials, treatments and community for Oculocutaneous albinism type 1 so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:352731 · OMIM 203100, 606952 · ICD-10 E70.3 · GARD 0004037

Find care for Oculocutaneous albinism type 1

Authoritative references for Oculocutaneous albinism type 1

Research & market landscape for Oculocutaneous albinism type 1

Following Oculocutaneous albinism type 1 for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Oculocutaneous albinism type 1 — the real-world landscape behind the condition, in one place.

Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Oculocutaneous albinism type 1 and every rare condition. See how Tomeko works with industry →

Common questions

What is Oculocutaneous albinism type 1?

Oculocutaneous albinism type 1 is a rare condition. Also known as OCA1. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Oculocutaneous albinism type 1 together in one place.

What are the symptoms of Oculocutaneous albinism type 1?

Symptoms of Oculocutaneous albinism type 1 vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Oculocutaneous albinism type 1.

How is Oculocutaneous albinism type 1 treated?

Treatment for Oculocutaneous albinism type 1 depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Oculocutaneous albinism type 1, and review current options with them.

What causes Oculocutaneous albinism type 1 — is it genetic?

The cause and inheritance of Oculocutaneous albinism type 1 are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Oculocutaneous albinism type 1 can explain what it means for you and your family.

I was just diagnosed with Oculocutaneous albinism type 1 — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Oculocutaneous albinism type 1, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Oculocutaneous albinism type 1?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Oculocutaneous albinism type 1, filtered to your area.

Are there clinical trials for Oculocutaneous albinism type 1?

Tomeko shows live, recruiting studies for Oculocutaneous albinism type 1 from ClinicalTrials.gov on the hub.

Related conditions

Other conditions on Tomeko you may be looking for: